Status:
COMPLETED
Tobacco Treatment Comparison for Cancer Care
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking Cessation
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This pilot comparative effectiveness trial will compare two active smoking cessation treatments in terms of effectiveness, equity across patient subpopulations, and efficiency among adult patients dia...
Detailed Description
Primary Aim 1\. To generate estimates of the size of the comparative effects of enhanced, cancer-specific smoking cessation treatment versus a generic standard care package similar to quitline care i...
Eligibility Criteria
Inclusion
- Alive (per medical record)
- Diagnosed with cancer in the past 3 years
- Received care from a participating oncology clinic in the past year
- Has a current tobacco use status
- Does not have a preferred language other than English (missing language preference will be included).
- Valid address that is not a correctional facility or residential treatment/care facility.
- No flag for patient cognitive impairment, activated health care power of attorney, or other health care agent (e.g., legally authorized representative) in the EHR.
- The following additional inclusion criteria must be met for inclusion in the CET
- Smoked combustible cigarettes in the past month.
- Able to speak and understand English.
- Willing to set a date to quit smoking in the next 60 days.
- Willing to receive smoking treatment information.
- Willing to complete study activities.
Exclusion
- No current suicidal ideation.
- Suicide attempt in the past year.
- Currently receiving treatment for bipolar disorder, schizophrenia, schizoaffective disorder, or psychotic disorder.
- Incarceration.
- Unable to provide informed consent to treatment (i.e., cannot answer questions about study procedures or risks after hearing about the study).
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 4 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06218823
Start Date
March 1 2024
End Date
August 4 2025
Last Update
October 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UW Carbone Cancer Center
Madison, Wisconsin, United States, 53792